this is a very bullish signal and will bring lots more momentum and swing traders into the stock here in the next week. Could rally hard past $5 with all these new chart buyers coming in. could get bad for the shorts here and we could get panic covering. April could be real good for longs.
insiders are on blackout with the study about to report data. they can't buy you dope. and not once insider has ever sold a single share of SGYP. you sound lame
I don't get what the point of the last year of games was. they hold it down at $2.80 forever and don't cover? we're now back to almost $5 and pretty much set up to go a lot higher with good data.
so if they didn't cover below $3 and just sat on this for a year, what was the whole point of it?
sounds fishy. new ID posting the sale was offered at $650M. so basically diluted at $4? the buyout will be $10
You probably would've done better with July options. They've already gone up 150% in 2 weeks
I think the short guys may try a push lower but the buying volume has been huge so any dip is a buy here. I think we see $4.60 by Friday and set up to go over $5 in April. This is just getting back to normal values here and the short guys are also looking to get out before we get too close to data. All adds up to $5+ very soon I think.
they can shake all they want, but data is just a couple weeks away. they are gonna have to do more than just shake to stop it from getting away from them I think
they look flat past two or three days. odd
this week. I think we see it settling high $3.90+ by Friday and then test mid $4s by end of the month. good job holding through the ups and downs, now let's see how much harder the short guys work next week.
hans, the mnkd short % of outstanding shares is 20%. for SGYP it is about 15% today. it's not that different from where I sit. and don't forget it was almost 19% this summer at the peak of the short interest. so we are controlled the same way as mnkd because the shorts have used 19% position in sgyp last year to keep the price down and covered only a little bit here.
Why hiding Tim?
he lies. he hasn't posted a single thing on the CUR board today as he claims he's all in on that stock with his tiny profit from flipping SGYP
Not sure if you've been watching closely but the bashers have been in control since they dumped like 100 million dollars in short shares last year. Don't see how you can say there are pumpers working here. If so they seriously stink at pumping.
But we have lots of good data coming that doesn't need any pumping and should drop some pain on the manipulating bashers.
that is good to know. I also think the differentiator for plecanatide will be the better tolerability. I think linzess is on target for $500 million in sales this year, am I grossly off base here? if so then imagine what a better tolerated drug like plecanatide can do in the market. seems patents are so desperate for anything that works that they are using linzess since it's really the only option right now.